by The City University of New York Graphical abstract. Credit: JAMA Internal Medicine (2022). DOI: 10.1001/jamainternmed.2022.0170 A study by CUNY SPH researchers, in close partnership with colleagues from Weill Cornell Medicine and NYU School of Medicine, suggests that treating people who inject drugs for hepatitis C infection using the accessible care model, which is characterized by low-threshold,...
